Expect a Busy Year in Obesity Drugs as New Pills Hit the Market
Barrons·2026-01-12 21:21

Core Viewpoint - Pill versions of the successful GLP-1 drugs from Novo Nordisk and Eli Lilly are expected to be available in the first half of 2026 [1] Company and Industry Summary - Novo Nordisk and Eli Lilly are leading companies in the GLP-1 drug market, which is anticipated to expand with the introduction of oral formulations [1]

Expect a Busy Year in Obesity Drugs as New Pills Hit the Market - Reportify